Daniel Boland

Daniel Boland

Pepper Hamilton LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Just How Much Integration Is Enough: FTC Advisory Opinion Finally Provides Guidance For Competitors Seeking To Collaborate Or...

The Federal Trade Commission (FTC) recently issued its first advisory opinion addressing clinical integration programs since the enactment of the Affordable Care Act (ACA). Without a doubt the advisory opinion is useful for...more

3/7/2013 - Affordable Care Act Blue Cross Blue Shield Clinical Integration Competition FTC Hospitals Insurers Norman PHO Physicians

Eaton Looks To U.S. Supreme Court For Help After Third Circuit Upholds

On February 25, 2013, Eaton Corporation (Eaton) filed a petition for certiorari to the United States Supreme Court seeking to reverse a jury verdict finding Eaton liable for illegal monopolization. In late 1999/early 2000,...more

3/7/2013 - Jury Verdicts Monopolization SCOTUS Sherman Act Supply Agreements The Clayton Act

Will FTC Chairman Leibowitz’s Departure Change The Enforcement Landscape?

After three years at the helm of the Federal Trade Commission (FTC), Chairman Jon Leibowitz stepped down. Without a doubt Chairman Leibowitz has been a visible and relentless advocate for restricting pay-for-day or reverse...more

3/7/2013 - Edith Ramirez FRAND FTC Generic Drugs Google Jon Leibowitz Pharmaceutical Patents Reverse Payment Settlement Agreements Watson Pharmaceuticals

3 Results
|
View per page
Page: of 1